drugset / Trial / NCT00162916
Antidepressant Maintenance in Traumatic Brain Injury
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of the study is to explore to what extent continuing the antidepressant medication citalopram (Celexa), after depression has responded to treatment, helps prevent the return of depressive symptoms in patients with recent traumatic brain injury (TBI).
Timeline
- Start
- 2005-05
- Primary completion
- 2008-05
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | 20 mg | — |
| Subject | Citalopram | Small molecule | 40 mg | — |